NDC 10135-754 – Haloperidol
Haloperidol 2 mg/1 · Tablet · Oral
Product NDC10135-754
Product details
- Brand name
- Haloperidol
- Generic name
- Haloperidol
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA071173
- Marketed since
- August 1, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Typical Antipsychotic
Active ingredients
- Haloperidol 2 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 10135-754-01 | 100 TABLET in 1 BOTTLE (10135-754-01) | Aug 1, 2022 |
| 10135-754-10 | 1000 TABLET in 1 BOTTLE (10135-754-10) | Aug 1, 2022 |
Other Haloperidol products
- 72888-173 Haloperidol 2 mg/mL · Solution, Concentrate · Advagen Pharma Ltd
- 11788-076 Haloperidol 20 mg/1 · Tablet · AiPing Pharmaceutical, Inc
- 11788-071 Haloperidol .5 mg/1 · Tablet · AiPing Pharmaceutical, Inc
- 11788-075 Haloperidol 10 mg/1 · Tablet · AiPing Pharmaceutical, Inc
- 11788-072 Haloperidol 1 mg/1 · Tablet · AiPing Pharmaceutical, Inc
- 11788-073 Haloperidol 2 mg/1 · Tablet · AiPing Pharmaceutical, Inc
- 11788-074 Haloperidol 5 mg/1 · Tablet · AiPing Pharmaceutical, Inc
- 60687-799 Haloperidol 2 mg/mL · Solution · American Health Packaging
- 68084-249 Haloperidol 10 mg/1 · Tablet · American Health Packaging
- 68084-250 Haloperidol 20 mg/1 · Tablet · American Health Packaging
- 60687-161 Haloperidol 5 mg/1 · Tablet · American Health Packaging
- 69292-580 Haloperidol .5 mg/1 · Tablet · Amici Pharmaceuticals, LLC